Senseera Revenue and Competitors
Estimated Revenue & Valuation
- Senseera's total funding is $8M.
Employee Data
- Senseera has 19 Employees.
- Senseera grew their employee count by 6% last year.
Senseera's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO at Senseera | Reveal Email/Phone |
2 | Co-Founder and CTO | Reveal Email/Phone |
3 | Co-Founder and VP R&D | Reveal Email/Phone |
4 | Chief Operations Officer | Reveal Email/Phone |
5 | Head Business Development | Reveal Email/Phone |
6 | Data Scientist | Reveal Email/Phone |
7 | Lead Data Scientist | Reveal Email/Phone |
8 | Research And Development Scientist | Reveal Email/Phone |
9 | R&D Associate Scientist | Reveal Email/Phone |
10 | Data Scientist | Reveal Email/Phone |
Senseera Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 23 | 53% | N/A | N/A |
#2 | N/A | 49 | 40% | $22M | N/A |
#3 | N/A | 32 | 7% | $23.4M | N/A |
#4 | N/A | 15 | -6% | $43M | N/A |
#5 | N/A | 43 | 26% | $12.5M | N/A |
#6 | N/A | 28 | 0% | N/A | N/A |
#7 | N/A | 24 | 9% | $16.1M | N/A |
#8 | N/A | 8 | 0% | N/A | N/A |
#9 | N/A | 19 | 6% | $8.44M | N/A |
#10 | N/A | 4 | 0% | N/A | N/A |
What Is Senseera?
Senseera's GEM (Genomic Expression Maps) BIOMARKERS, is a novel biomarker discovery platform based on a patent protected chromatin epigenomics (cfChIP-seq) liquid biopsy technology (Sadeh, Nature Biotechnology, 2021). \n\nGEM BIOMARKERS turns a simple blood draw into unparalleled, quantitative, cell-specific gene expression, and regulation data from cell-free DNA. Going beyond traditional methods like cfDNA genomics and methylation, it offers a transformative layer of data for various applications including biomarker discovery, tissue-agnostic MRD detection, response to therapy, dose optimization, disease subtyping and more.\n\nBacked by a database of over 20,000 annotated disease samples and a 2,000+ healthy subjects cohort, Senseera is collaborating with leading drug developers from big pharma and biotechs, to deliver mechanistic insights with exceptional sensitivity and specificity across multiple indications, advancing human health and precision medicine worldwide.
keywords:N/A$8M
Total Funding
19
Number of Employees
N/A
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 19 | 46% | N/A |
#2 | $3.7M | 22 | -12% | N/A |
#3 | $6.2M | 22 | -27% | N/A |
#4 | $3M | 26 | 13% | N/A |
#5 | $7.3M | 26 | 8% | N/A |